Disorders of cholesterol metabolism and their unanticipated convergent mechanisms of disease.
Frances M. Platt,Christopher A. Wassif,Alexandria Colaco,Andrea Dardis,Emyr Lloyd-Evans,Bruno Bembi,Forbes D. Porter +6 more
Reads0
Chats0
TLDR
A surprising finding is not only shedding light on details of cellular cholesterol homeostasis but also suggesting novel approaches to therapy.Abstract:
Cholesterol plays a key role in many cellular processes, and is generated by cells through de novo biosynthesis or acquired from exogenous sources through the uptake of low-density lipoproteins. Cholesterol biosynthesis is a complex, multienzyme-catalyzed pathway involving a series of sequentially acting enzymes. Inherited defects in genes encoding cholesterol biosynthetic enzymes or other regulators of cholesterol homeostasis result in severe metabolic diseases, many of which are rare in the general population and currently without effective therapy. Historically, these diseases have been viewed as discrete disorders, each with its own genetic cause and distinct pathogenic cascades that lead to its specific clinical features. However, studies have recently shown that three of these diseases have an unanticipated mechanistic convergence. This surprising finding is not only shedding light on details of cellular cholesterol homeostasis but also suggesting novel approaches to therapy.read more
Citations
More filters
Journal ArticleDOI
Complex lipid trafficking in Niemann-Pick disease type C.
TL;DR: A reappraisal of lipid storage and lysosomal enzymes activities in tissues/cells from NPC patients and animal models is provided, with emphasis on differences between systemic organs and the brain.
Journal ArticleDOI
Emptying the stores: lysosomal diseases and therapeutic strategies
TL;DR: Despite ongoing challenges, various therapeutic strategies for LSDs now exist, with many agents approved, undergoing clinical trials or in preclinical development.
Journal ArticleDOI
Diagnostic tests for Niemann-Pick disease type C (NP-C): A critical review.
Marie T. Vanier,Paul Gissen,Paul Gissen,Peter Bauer,Maria Josep Coll,Alberto Burlina,Christian J. Hendriksz,Christian J. Hendriksz,Philippe Latour,Cyril Goizet,Richard W. D. Welford,Thorsten Marquardt,Stefan A. Kolb +12 more
TL;DR: Advances in mass spectrometry has allowed identification of several sensitive plasma biomarkers elevated in NP-C, which, together with the concomitant progress in molecular genetic technology, have greatly impacted the strategy of laboratory testing.
Book ChapterDOI
Laboratory diagnosis of Niemann–Pick disease type C: The filipin staining test
Marie T. Vanier,Philippe Latour +1 more
TL;DR: Methodological caveats and variability of patterns encountered in patients with proven Niemann-Pick C disease (typical "classic" or "intermediate," atypical "variant") are described, leading to a proposed algorithm for interpretation of results in the filipin test.
Journal ArticleDOI
A comparative study on fluorescent cholesterol analogs as versatile cellular reporters
Erdinc Sezgin,Fatma Betul Can,Falk Schneider,Mathias P. Clausen,Mathias P. Clausen,Silvia Galiani,Tess A. Stanly,Dominic Waithe,Alexandria Colaco,Alf Honigmann,Daniel Wüstner,Frances M. Platt,Christian Eggeling +12 more
TL;DR: Different fluorescent lipid analogs are compared for their performance in cellular assays and their applicability in fluorescence correlation spectroscopy (FCS)-based and super-resolution stimulated emission depletion-FCS-based measurements of membrane diffusion dynamics.
References
More filters
Journal ArticleDOI
Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin.
Mylvaganam Jeyakumar,T D Butters,Mario Cortina-Borja,V Hunnam,Richard L. Proia,V H Perry,Raymond A. Dwek,Frances M. Platt +7 more
TL;DR: A mouse model of Sandhoff disease is treated with the inhibitor N-butyldeoxynojirimycin and the treated mice have delayed symptom onset, reduced storage in the brain and peripheral tissues, and increased life expectancy.
Journal ArticleDOI
The Inheritance of Essential Familial Hypercholesterolemia
TL;DR: The occurrence of xanthomatosis in the heterozygote as well as in the homozygote reconciles the opposing theories for the inheritance of the disorder.
Journal ArticleDOI
Tangier Disease: Combined Clinical Staff Conference at the National Institutes of Health
Donald S. Fredrickson,Paul H. Altrocchi,Louis V. Avioli,De Witt S. Goodman,Howard C. Goodman +4 more
Journal ArticleDOI
Regulation of cholesterol homeostasis.
TL;DR: The recent advances in the post-transcriptional regulation of cholesterol homeostasis, including the role of small non-coding RNAs (microRNAs), are discussed, which may open new avenues for the treatment of dyslipidemias and cardiovascular diseases.
Journal ArticleDOI
NPC1 and NPC2 regulate cellular cholesterol homeostasis through generation of low density lipoprotein cholesterol-derived oxysterols.
Andrey Frolov,Sarah E. Zielinski,Jan R. Crowley,Nicole Dudley-Rucker,Jean E. Schaffer,Daniel S. Ory +5 more
TL;DR: Findings support a role for NPC1 and NPC2 in the regulation of sterol homeostasis through generation of LDL cholesterol-derived oxysterols and have important implications for the treatment of NPC disease.